Repository logo
 

Wild Type and Gain of Function Mutant TP53 can Regulate the Sensitivity of Pancreatic Cancer Cells to Chemotherapeutic Drugs, EGFR/Ras/Raf/MEK, and PI3K/mTORC1/GSK-3 Pathway Inhibitors, Nutraceuticals and Alter Metabolic Properties

This item will be available on:

Authors

McCubrey, James A.
Meher, Akshaya K.
Akula, Shaw M.
Abrams, Stephen L.
Steelman, Linda S.
LaHair, Michelle M.
Franklin, Richard A.
Martelli, Alberto M.
Ratti, Stefano
Cocco, Lucio

Journal Title

Journal ISSN

Volume Title

Publisher

Abstract

Description

Citation

item.page.doi

10.18632/aging.204038